Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preclinical evaluation and first-in-dog clinical trials of PBMC-expanded natural killer cells for adoptive immunotherapy in dogs with cancer.
Razmara AM, Farley LE, Harris RM, Judge SJ, Lammers M, Iranpur KR, Johnson EG, Dunai C, Murphy WJ, Brown CT, Rebhun RB, Kent MS, Canter RJ. Razmara AM, et al. Among authors: canter rj. J Immunother Cancer. 2024 Apr 16;12(4):e007963. doi: 10.1136/jitc-2023-007963. J Immunother Cancer. 2024. PMID: 38631708 Free PMC article.
NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype.
Ames E, Canter RJ, Grossenbacher SK, Mac S, Chen M, Smith RC, Hagino T, Perez-Cunningham J, Sckisel GD, Urayama S, Monjazeb AM, Fragoso RC, Sayers TJ, Murphy WJ. Ames E, et al. Among authors: canter rj. J Immunol. 2015 Oct 15;195(8):4010-9. doi: 10.4049/jimmunol.1500447. Epub 2015 Sep 11. J Immunol. 2015. PMID: 26363055 Free PMC article.
Blocking Indolamine-2,3-Dioxygenase Rebound Immune Suppression Boosts Antitumor Effects of Radio-Immunotherapy in Murine Models and Spontaneous Canine Malignancies.
Monjazeb AM, Kent MS, Grossenbacher SK, Mall C, Zamora AE, Mirsoian A, Chen M, Kol A, Shiao SL, Reddy A, Perks JR, T N Culp W, Sparger EE, Canter RJ, Sckisel GD, Murphy WJ. Monjazeb AM, et al. Among authors: canter rj. Clin Cancer Res. 2016 Sep 1;22(17):4328-40. doi: 10.1158/1078-0432.CCR-15-3026. Epub 2016 Mar 15. Clin Cancer Res. 2016. PMID: 26979392 Free PMC article.
Natural killer cell immunotherapy to target stem-like tumor cells.
Grossenbacher SK, Canter RJ, Murphy WJ. Grossenbacher SK, et al. Among authors: canter rj. J Immunother Cancer. 2016 Apr 19;4:19. doi: 10.1186/s40425-016-0124-2. eCollection 2016. J Immunother Cancer. 2016. PMID: 27096096 Free PMC article.
Targeting Cancer Stem Cells with Natural Killer Cell Immunotherapy.
Luna JI, Grossenbacher SK, Murphy WJ, Canter RJ. Luna JI, et al. Among authors: canter rj. Expert Opin Biol Ther. 2017 Mar;17(3):313-324. doi: 10.1080/14712598.2017.1271874. Epub 2016 Dec 23. Expert Opin Biol Ther. 2017. PMID: 27960589 Free PMC article. Review.
Canine cancer immunotherapy studies: linking mouse and human.
Park JS, Withers SS, Modiano JF, Kent MS, Chen M, Luna JI, Culp WTN, Sparger EE, Rebhun RB, Monjazeb AM, Murphy WJ, Canter RJ. Park JS, et al. Among authors: canter rj. J Immunother Cancer. 2016 Dec 20;4:97. doi: 10.1186/s40425-016-0200-7. eCollection 2016. J Immunother Cancer. 2016. PMID: 28031824 Free PMC article. Review.
191 results